Kansas City Heart Rhythm Research Foundation
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Kansas City Heart Rhythm Research Foundation sits in the top decile of US sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count).
Kansas City Heart Rhythm Research Foundation: 22 sponsored US clinical trials, 9 recruiting.
Kansas City Heart Rhythm Research Foundation sponsors 22 registered US clinical trials on ClinicalTrials.gov, 9 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Atrial Fibrillation, with 3 trials.
Top-decile sponsor footprint
Kansas City Heart Rhythm Research Foundation ranks in the top decile of sponsors by registered trial count (#696 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
22 total, page 1 of 1
Autonomic Dysfunction in Patients Following Bariatric Surgery: The ADiPOSE Study
NCT06289413
Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure
NCT06342492
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
NCT06078735
Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System
NCT05826665
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
NCT06055751
Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
NCT06075628
Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure
NCT06061757
Role of Novel ILR in the Management of PVCs
NCT06060548
HS Students Mandatory Universal Student Instruction in CPR Appraised Learning- Is the Mandate Working?
NCT04493970
Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket Pain
NCT05575999
The ORCHESTRATE-Myocarditis Registry
NCT05139329
Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)
NCT06672861
Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
NCT05158751
Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET
NCT05464511
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
NCT06783868
Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction
NCT05464940
Efficacy Rate of Unipolar Polarity Switch for Lesion Assessment in Pulmonary Vein Isolation
NCT05464537
Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry
NCT06052358
Accuracy of Rhythm Detection by a Wearable Smart Watch for Cardiac Arrhythmias (The WATCH-RHYTHM Study)
NCT04499807
Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients
NCT04465552
Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study
NCT06352060
Multimodality Evaluation of LAA Leaks Arising After Incomplete LAAC: Insights From the LAA-Leak Registry
NCT05131308
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
What is open in the Kansas City Heart Rhythm Research Foundation pipeline
9 recruiting of 22 indexed (41% open); 3 completed (14%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Atrial Fibrillation (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Kansas City Heart Rhythm Research Foundation: open-pipeline peers nationwide
Peers matched on 22 registered trials and 41% open enrollment, not the therapeutic-area sidebar.
Kansas City Heart Rhythm Research Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 22 trials (± recruiting share)
- Alaunos Therapeutics · 22 trials · 0% recruiting
- Alexza Pharmaceuticals · 22 trials · 0% recruiting
- Calithera Biosciences · 22 trials · 0% recruiting
- Fate Therapeutics · 22 trials · 14% recruiting
Sponsors near 41% open enrollment (± trial volume)
- Uniformed Services University of the Health Sciences · 41% recruiting · 27 trials
- University of Vermont Medical Center · 41% recruiting · 27 trials
- Arthrex · 42% recruiting · 12 trials
- Diwakar Davar · 42% recruiting · 12 trials
Related
What to do with this Kansas City Heart Rhythm Research Foundation page
22 registered trials is a research-attention snapshot, not an endorsement of Kansas City Heart Rhythm Research Foundation or any single study.
- 9 of Kansas City Heart Rhythm Research Foundation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Atrial Fibrillation is the condition Kansas City Heart Rhythm Research Foundation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atrial Fibrillation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Kansas City Heart Rhythm Research Foundation pipeline card: 22 registered trials from official public datasets.Report a data error.